National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 02:25:32

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0075-2912-02	ML - Milliliter	0075-2912	a8561196-d98d-456b-9db0-91eb5b0fa951	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0075-2912	0075-2912-02

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020164-001	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29
N020164-002	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30
N020164-003	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27
N020164-004	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27
N020164-005	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27
N020164-006	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02
N020164-007	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02
N020164-008	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02
N020164-009	LOVENOX	ENOXAPARIN SODIUM	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 8 matching rows.

Application-product, TE code table
Application-product	TE code
N020164-001	AP
N020164-002	AP
N020164-003	AP
N020164-004	AP
N020164-005	AP
N020164-007	AP
N020164-008	AP
N020164-009	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 10 · 387 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`6a471c1ec25d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 9 · 344 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N020164-001	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-002	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-003	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-004	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-005	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-007	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-008	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020164-009	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020164-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-003	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-004	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-005	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-007	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-008	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-009	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020164-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-004	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-005	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-007	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-008	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-009	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-004	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-005	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-007	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-008	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-009	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020164-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-004	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-005	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-007	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-008	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-009	AB	1	`6a471c1ec25d…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.